163,834 Shares in Prestige Consumer Healthcare Inc. $PBH Bought by Congress Asset Management Co.

Key Points

• Congress Asset Management purchased 163,834 shares of Prestige Consumer Healthcare, valued at approximately $7.5 million, giving it a 0.35% stake. Institutional investors collectively own 99.95% of the company.
• Prestige Consumer Healthcare reported quarterly EPS of $0.98, exceeding estimates of $0.89, while revenue rose 6.5% year over year to $265.71 million. Management’s FY 2027 EPS guidance is $4.55–$4.65.
• PBH shares recently traded at $47.57, well below the analyst average price target of $67.67. Analyst sentiment remains mixed, with the stock carrying an overall “Hold” rating despite a recent Zacks upgrade to “Strong Buy.”

Congress Asset Management Co. purchased a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 163,834 shares of the company's stock, valued at approximately $7,515,000. Congress Asset Management Co. owned about 0.35% of Prestige Consumer Healthcare as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of Prestige Consumer Healthcare during the second quarter worth $370,187,000. Rice Hall James & Associates LLC acquired a new position in Prestige Consumer Healthcare in the second quarter valued at $32,602,000. The Manufacturers Life Insurance Company acquired a new position in Prestige Consumer Healthcare in the second quarter valued at $31,135,000. Bank of America Corp DE bought a new stake in Prestige Consumer Healthcare during the second quarter valued at $26,277,000. Finally, Bank of New York Mellon Corp bought a new stake in Prestige Consumer Healthcare during the second quarter valued at $15,376,000. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Up 2.4%

NYSE:PBH opened at $47.57 on Thursday. Prestige Consumer Healthcare Inc. has a 12 month low of $42.62 and a 12 month high of $71.07. The company has a current ratio of 3.23, a quick ratio of 1.99 and a debt-to-equity ratio of 1.06. The stock has a market capitalization of $2.25 billion, a price-to-earnings ratio of 13.33, a PEG ratio of 1.46 and a beta of 0.34. The firm has a fifty day simple moving average of $49.68 and a two-hundred day simple moving average of $50.91.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.09. The business had revenue of $265.71 million during the quarter, compared to analyst estimates of $253.02 million. Prestige Consumer Healthcare had a return on equity of 11.39% and a net margin of 15.57%.The firm's revenue was up 6.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.90 EPS. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. Analysts expect that Prestige Consumer Healthcare Inc. will post 4.56 EPS for the current fiscal year.

Analysts Set New Price Targets

PBH has been the topic of several research analyst reports. Zacks Research upgraded Prestige Consumer Healthcare from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, September 30th. Weiss Ratings reiterated a "sell (d+)" rating on shares of Prestige Consumer Healthcare in a report on Tuesday, September 22nd. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $67.67.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc NYSE: PBH is a consumer healthcare company that develops, markets and distributes over-the-counter (OTC) products and household health-care brands. Its portfolio includes products for eye care, oral care, gastrointestinal health, pain relief, respiratory health, women's health, and other everyday health needs.

The company's brands include Dramamine, Bonine, BC, Goody's, Clear Eyes, TheraTears, Monistat, Summer's Eve, Vagisil, Luden's, Chloraseptic, Compound W, Fleet and Debrox.

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.